Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Singular Genomics Systems, Inc. (OMIC)

2.08   0 (0%) 11-28 10:17
Open: 2.07 Pre. Close: 2.08
High: 2.11 Low: 2.07
Volume: 6,061 Market Cap: 149(M)

Technical analysis

as of: 2022-11-28 9:50:56 AM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 2.94     One year: 3.38
Support: Support1: 1.89    Support2: 1.58
Resistance: Resistance1: 2.51    Resistance2: 2.9
Pivot: 2.16
Moving Average: MA(5): 2.07     MA(20): 2.24
MA(100): 2.99     MA(250): 5.03
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 29.2     %D(3): 25.8
RSI: RSI(14): 44
52-week: High: 12.43  Low: 1.89
Average Vol(K): 3-Month: 229 (K)  10-Days: 108 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ OMIC ] has closed above bottom band by 41.0%. Bollinger Bands are 43.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.19 - 2.2 2.2 - 2.22
Low: 2 - 2.02 2.02 - 2.03
Close: 2.06 - 2.08 2.08 - 2.1

Company Description

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Headline News

Mon, 28 Nov 2022
New Director: PCC announces appointment for OMIC | News | - St. Helens Chronicle

Fri, 25 Nov 2022
An Integrated Omics Guided Approach to Lignification and Gravitational Responses: The Final Frontier (Plant Habitat-01) | Science Mission Directorate - Science@NASA

Tue, 22 Nov 2022
Jennifer Smith Lecture - MSU Sociology!

Thu, 17 Nov 2022
OMIC takes over Jet Black Weekend: panels, networking, showcases Nov. 26 at Club SAW – Apartment613 - Apt613

Mon, 14 Nov 2022
Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds | Scientific Data -

Sat, 12 Nov 2022
Omics Research Center / jaq - ArchDaily

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 71 (M)
Shares Float 41 (M)
% Held by Insiders 19.1 (%)
% Held by Institutions 70 (%)
Shares Short 2,830 (K)
Shares Short P.Month 3,220 (K)

Stock Financials

EPS 0.1
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.88
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -15.9
Return on Equity (ttm) -28.5
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.25
Qtrly Earnings Growth 0
Operating Cash Flow -83 (M)
Levered Free Cash Flow -56 (M)

Stock Valuations

PE Ratio 21.09
PEG Ratio -0.2
Price to Book value 0.54
Price to Sales 0
Price to Cash Flow -1.82

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.